Traditionally, patients act for “Indica” for sleep and “Sativa” for energy. While these terms are useful vernacular, they are botanically outdated and often inaccurate for predicting medical effects in modern hybrid genetics.

At 300 Genetics, we encourage moving towards a “Chemovar” (chemical variety) approach for medical selection.

The Limits of Old Labels

A plant looking like a Sativa can have a sedating terpene profile, and vice-versa. Relying on these labels can lead to inconsistent therapeutic outcomes for patients.

The Clinical Alternative: Chemovars

We categorize our medical flowers based on their actual chemical composition—the specific ratio of THC, CBD, and dominant terpenes as confirmed by lab tests.

• Type I Chemovars (High THC dominant): Used for severe pain, appetite stimulation, etc.

Type II Chemovars (Balanced THC/CBD): Often used for inflammation and anxiety where less psychoactivity is desired.
By focusing on data rather than outdated names, clinicians can better match the right product to the patient’s specific symptoms.